Expression of cell-surface markers was studied in mice on ovalbumin (OVA)-specifi c T cells in the gut-draining mesenteric lymph nodes (MLN) after OVA feed. The effect of the local mucosal mediators retinoic acid (RA) and transforming growth factor-␤ (TGF -␤ ) on the induction of a mucosal phenotype was determined in in vitro T-cell differentiation assays with murine and human T cells. Tetramer stainings were performed to study gluten-specifi c T cells in the circulation of patients with celiac disease, a chronic small-intestinal infl ammation. 
INTRODUCTION
Th e mucosal surfaces of our gastrointestinal tract are continuously exposed to foreign antigens. While infl ammatory immune responses are needed to eliminate invasive bacteria and protect the body from infection, harmless soluble proteins and commensal fl ora induce mucosal tolerance ( 1 ) . Inappropriate regulation of these responses can lead to chronic infl ammatory disorders of the intestine such as celiac disease caused by intolerance to the dietary protein gluten and infl ammatory bowel diseases (IBDs) caused by an aberrant infl ammatory response to intestinal microbiota. Despite signifi cant advances in the understanding of celiac disease and IBD ongoing T-cell responses in patients are diffi cult to study, as T cells from mucosal origin are not easily identifi ed in peripheral blood.
Both eff ector T (Te) cells and regulatory T cells (Treg) diff erentiate from naive T cells upon antigen presentation by mucosal dendritic cells (DC ) in the Peyer ' s Patches and gut-draining mesenteric lymph nodes (MLN) following antigen feed ( 2 -4 ) . Upon activation in the Peyer ' s Patches or MLN, T cells acquire high expression levels of the integrin α 4 β 7 and the chemokine receptor CCR9 that allow their migration to the small intestine ( 5 -7 ) . Imprinting of this gut-homing phenotype is effi ciently induced in response to protein feed regardless of the functional outcome of the T-cell response, as CCR9 is effi ciently induced both in the absence and presence of the mucosal adjuvant cholera toxin (CT) ( 8 ) .
Although the role for CCR9 in migration to the small intestine is well established, the expression of CCR9 is not absolutely required for the localization of CD4 + T cells in the small intestine ( 9 ) . CCR9 − / − mice have normal numbers of CD4 + T cells in the small intestine whereas the CD8 + population is reduced ( 10 -11 ) . In agreement with these fi ndings, CD4 + T cells in the lamina propria express a more heterogeneous chemokine receptor profi le including CCR9, CXCR3, CXCR6, as well as CCR5 and CCR6 ( 12 ) . Moreover, expression of CCR9 on human peripheral blood T cells does not seem to be restricted to gut-migrating T cells, as CCR9 expressing naive T cells can be found that lack α 4 β 7 and are presumed to be recent thymic emigrants ( 13 ) . In addition, a large proportion of α 4 β 7 + T cells in blood do not express CCR9 ( 13 ) . Th ese fi ndings indicate that CCR9 may not exclusively identify all gut-imprinted T cells in peripheral blood.
Hence, we investigated whether mucosal imprinting results in a distinctive phenotype that could be used to identify mucosally educated T cells in the periphery.
METHODS
For detailed description of antibodies and primers see Supplementary data online.
Mice
BALB / c mice (Charles River, Maastricht, Th e Netherlands), DO11.10 transgenic (Tg) and DO11.10TgxRAG − / − mice (breeding at Erasmus MC), which have a Tg T-cell receptor (TCR) for the ovalbumin (OVA) 323 -339 peptide were kept under routine animal housing conditions. Experiments were approved by the animal experimental committee of the Erasmus MC.
Adoptive transfer and CFSE labeling
BALB / c mice received an intravenous injection of 6 -10 × 10 6 5,6-carboxy-succinimidyl-fl uoresceine-ester (CFSE)-labeled DO11.10 cells as described previously ( 2, 14 ) . Th e next day, mice received 70 mg 98 % pure OVA (Sigma Aldrich, Zwijndrecht, Th e Netherlands) intragastrically (IG) or 400 μ g OVA (Calbiochem, San Diego, CA) intramuscularly (IM). To break tolerance, mice received 70 mg OVA with 20 μ g CT (Sigma Aldrich ) IG. At 72 h aft er OVA, cells from draining lymph node (LN) and spleen were stained for CD4, CD38, CD62L, Foxp3, and DO11. 10 Figure 1 online) . DC from MLN, peripheral LN (PLN), and spleens for OVAspecifi c T-cell diff erentiation assays were obtained as described previously ( 15 ) . Naive CD4 + KJ1.26 + T cells were obtained from LN and spleens of DO11.10TgxRAG − / − mice by positive selection using biotinylated KJ1.26 and the CELLection biotin-binder kit (Invi trogen, Carlsbad, CA). In all, 2 × 10 4 DC were cultured with 5 × 10 5 CFSE-labeled CD4 + KJ1.26 + cells, OVA 323 -339 peptide for 96 h and / or 20 ng / ml rhTGF-β (Preprotech, Rocky Hill, NJ) and 10 n M retinoic acid (RA) (Sigma). Concentrations of rhTGF-β and RA were determined in a dose response experiment and chosen based on optimal induction of Foxp3 (not shown). In some experiments, recIL-4 (300 ng / ml, R & D systems, Abingdon, UK), lipopolysaccharide (LPS) ( E. coli 0111:B4, 100 ng / ml, Difco, Detroit, MI), RAreceptor antagonists LE540 (10 μ M , Wako Chemical, Osaka, Japan) or LE135 (10 μ M , Tocris Bioscience, Bristol, UK) were added.
In vitro T-cell differentiation assays (mouse)

Peripheral blood
Healthy controls . Peripheral blood cells from healthy volunteers were stained for CD4, CD38, CD62L, CD45RA, Foxp3, CCR9, CLA, β 7 integrin, and isotype control. Peripheral blood mononuclear cells (PBMC) were isolated and stimulated with CD3 / CD28 T-cell expander beads (Dynal, Hamburg, Germany) in the presence of 20 ng / ml rhTGF-β and / or 10 n M RA. Aft er 96 h, the cells were analyzed by fl ow cytometry. All participants gave written informed consent for the study. Adult celiac disease patients . For detection of gluten-specifi c T cells in blood, six celiac disease patients on gluten-free diet were recruited (study approved by the Regional Ethics Committee for Southern Norway). Th e patients ate four slices of standard white bread daily for 3 days ( ~ 160 g, Bakers AS, Oslo, Norway), thereaft er continued their gluten-free diet. On day 6, blood was drawn and gluten-reactive T cells were stained with tetramers as described below and reported previously ( 17 ) .
Biopsies
Duodenal biopsy specimens were obtained from patients who underwent gastroendoscopy for their diagnostic work-up for abdominal pain and diarrhea (two patients) or Barrett ' s esophagus (one patient). Histology revealed normal mucosal architecture. Epithelium was removed by incubation in 2 m M EDTA (2 × 30 min), followed by digestion of the tissue in 1 mg / ml collagenase H (Sigma). Cells were stained with antibodies to CD45, CD62L, CD4, CD38, TCR α β and 0.2 μ g / ml propidium iodide to exclude dead cells. Collection of clinical samples was approved by the Regional Ethics Committee for Southern Norway and the patients gave written informed consent.
Gliadin-specifi c T-cell staining using α -gliadin tetramers
Water-soluble DQ2 (DQA1 * 0501 / DQB1 * 0201) molecules with three diff erent peptides were produced as previously described ( 17 ) : two gliadin tetramers with deamidated T-cell epitopes of α -gliadin (i.e., DQ2-α I tetramer and DQ2-α II tetramer) and one control tetramer containing the invariant chain peptide CLIP2 ( 18 ) . Tetramers were made by conjugating DQ2 -peptide complexes with streptavidin-PE (Molecular Probes, Eugene, OR). Specifi city of the tetramers was assessed aft er conjugation by staining two T-cell clones TCC 380.E.2 (specifi c for the DQ2-α -I epitope) and TCC 412.5.28 (specifi c for the DQ2-α -II epitope) with all three DQ2 tetramers. CD4 + lymphocytes were isolated from PBMC by positive selection (Invitrogen) and stained as described previously ( 17 ) with slight modifi cations. Briefl y, 1 -4 million CD4 + T cells were stained in 100 μ l with 10 μ g / ml tetramer at 37 ° C, cooled and stained with specifi c antibodies: CD62L, CD38, CD11c, CD45RA, CD4 and CCR9. At least 0.8 million cells were analyzed by fl ow cytometry.
Quantitative PCR
RNA was purifi ed from purifi ed murine CD4 + T cells or T-cell subsets using the Nucleospin RNA-XS kit (Macherey-Nagel, D ü ren, Germany) and cDNA was synthesized. Real-time quantitative PCR was performed using SYBRgreen (Finnzymes, Espoo, Finland) on an AbiPrismR7900 Sequence Detection System (PE Applied Biosystems, Foster City, CA). Relative expression to cyclophillin was calculated as follows: relative expression = 2 − Δ Ct , whereby Δ Ct = Ct target -Ct housekeeping . Primers are specifi ed in Supplementary methods online.
Statistics
Data are expressed as the mean ± s.d. and analyzed using either Student ' s t -test or analysis of variance. P < 0.05 was considered signifi cant. 
RESULTS
Under
CD38
+ expression is characteristic for gut-imprinted cells in vivo , we compared the T-cell response in the gut-draining MLN aft er OVA feed with the T-cell response in popliteal and inguinal LN referred to as PLN aft er IM OVA injection. Expression of CD62L rapidly decreased upon diff erentiation of tolerogenic OVA-specifi c T cells in the MLN aft er OVA feed, whereas expression levels remained high on diff erentiating T cells in the PLN aft er OVA IM ( Figure 1a ) . Th e diff erentiating CD62L + T cells in the PLN co-expressed high levels of CD25 (not shown). Moreover, the CD62L + phenotype remained upon injection of OVA in incomplete Freund ' s adjuvant, indicating that the absence of CD62L downregulation is not due to suboptimal T-cell activation (not shown). As a result, the percentage of cells that had become CD62L neg in the MLN was signifi cantly higher in comparison with the PLN ( Figure 1b int phenotype is characteristic for T cells that diff erentiate in the MLN aft er protein feed ( Figure 1c ). Diff erentiating MLN T cells elicited by OVA feed are Tregs that suppress an infl ammatory delayed-type hypersensitivity response upon adoptive transfer ( 2 ) . A proportion of these Treg de novo expresses Foxp3 ( 15 ) ( Figure 1d ) and a four-fold increase in CD38 mRNA levels compared with polyclonal stimulation alone ( Figure 2c ). No eff ect on CD38 expression was observed when RA was used alone (not shown). Th us, RA and TGF-β drive reduction of CD62L and increase CD38 expression on diff erentiating mucosal Tregs.
Next, we assessed whether mucosal DC, that are able to convert vitamin-A into RA ( 19 ) , are more effi cient in inducing a ing of CD38 expression. Moreover, interference with RA signaling resulted in a reduction of CD62L neg cells ( Figure 3b ). Addition of exogenous RA together with TGF-β to T cells cultured with OVA-loaded MLN-DC further increased the expression of CD38 ( Figure 3c ; Supplementary Figure 4B online). Furthermore, exogenous RA and TGF-β abolished the diff erences between mucosal and non-mucosal DC in the imprinting of CD38 expression on T cells ( Figure 3d ). In sum, in the presence of TGF-β , mucosal DC effi ciently induce expression of CD62L neg CD38
+ on diff erentiating T cells in an RA-dependent manner.
CD38 is expressed irrespective of regulatory or effector T-cell function
To test whether the imprinting of the CD62L 
Gluten-specifi c T cells are mainly detected in the CD62L
neg CD38 + CD4 + T-cell subset
Finally, we wished to examine a human disease to demonstrate that the CD62L neg CD38 + T-cell phenotype can be used to detect gut-imprinted T cells. Gluten-specifi c T cells, restricted by the disease-associated DQ2 molecule and likely involved in the formation of celiac lesion in the small intestine, can be cultured from the duodenal mucosa of celiac patients but not of healthy individuals ( 23 ) . In blood, these gluten-specifi c T cells can only
CD4
+ CD62L neg subsets were CD45RA neg ( Figure 5d ) be detected aft er a short dietary gluten challenge in celiac disease patients that have been restricted to a gluten-free diet ( 17, 24 ) . To establish that the CD62L neg CD38 + T-cell population indeed contains gluten-specifi c T cells, six treated adult celiac patients were recruited and ate four slices of gluten-containing bread daily for 3 days. At day 6, CD4 + PBMC were isolated and stained with both control and gluten tetramers (DQ2-α I and DQ2-α II), as well as antibodies against CD62L, CD38, and CCR9. In agreement with earlier observations ( 17 ) , in 4 of the 6 patients, 0.01 -0.1 % of the CD4 + T cells bound the tetramers ( Figure 6a ). In one patient, no gluten-specifi c cells were detected by tetramer staining. In another patient, the background staining with the control tetramer was very high precluding proper analysis. Th e majority of the tetramer + T cells had a CD62L neg CD38 + phenotype, as demonstrated in the analysis of these cells from the four remaining patients ( Figure 6b and c ) . Surprisingly, although most gluten-specifi c T cells were shown to express the β 7 integrin ( 17 ), CCR9 was expressed by only 10 -30 % of tetramer + cells ( Figure 6c ). Taken together, these results suggest the use of the CD62L neg CD38 + T-cell phenotype to characterize ongoing mucosal immune responses in peripheral blood of patients with chronic intestinal disease. with the data from the celiac disease patients, no signifi cant diff erences in the percentage of CD62L neg CD38 + CD4 + mucosal T cells were observed ( Figure 7b ) .
From these data, we conclude that the total percentage of circulating CD62L neg CD38 + in the CD4 + T-cell pool is not an indicator of intestinal infl ammation. Th is absence of quantitative diff erences in circulating lymphocytes is a phenomenon that is not restricted to intestinal disease, but also seen in other chronic mucosal disease such as chronic pulmonary disease. However, in chronic obstructive pulmonary disease signifi cant advantages have been made by correlating peripheral T-cell cytokine profi les with severity of disease ( 25 ) . Th erefore, we examined whether sorted CD62L neg CD38 + CD4 + T cells from healthy donors exhibited detectable cytokine profi les by quantitative PCR. Indeed, in healthy controls interleukin-10 (IL-10) and interferon-γ (IFN-γ ) transcripts were readily detected in highly purifi ed CD62L neg CD38 + CD4 + T cells demonstrating that functional analysis is feasible ( Figure 7c ) + CD4 + mucosal T-cell population no diff erences in the percentages of the cells were found between pediatric celiac disease patients and controls ( Figure 7a ). Th is fi nding may have been expected as previous studies have shown that circulating gliadin-reactive T cells can only be detected in patients that have received a gluten challenge ( 17, 24 ) .
Similarly, the percentage of CD62L neg CD38 + CD4 + mucosal T cells was also determined in peripheral blood of IBD patients. As such 21 Crohn ' s disease patients, 8 ulcerative colitis patients and 14 age matched orthopedic control patients with no underlying infl ammatory or intestinal diseases were investigated. In agreement a b 20 20 n.s. n.s. + cells from a healthy donor were cell sorted into four CD62L / CD38 subsets and restimulated with phorbol myristate acetate (0.05 μ g / ml) and ionomycin (0.5 μ g / ml) during 5 h. IL-10 (left) and IFN-γ (right) mRNA expression were determined relative to GAPDH. n.s. denotes P > 0.05. ( 26 ) . Regarding CD38, it has been reported that human lamina propria T cells express CD38 at higher levels than circulating T cells ( 27 ) . In addition, the majority of CD4 + CD25 + T cells in the lamina propria, but not in the MLN or the spleen, lack expression of CD62L ( 27 ) . It is unlikely that the CD62L neg phenotype of lymphocytes in mucosal tissues is the result of continuous activation as we show that T-cell activation induced by IM protein injection does not induce this phenotype. For CD8 + T cells, CD62L expression can depend on the initial frequency of naive T cells and on the strength of the T-cell activation ( 31 ) . In our in vivo model transfer of various numbers of T cells, resulting in diff erent antigen presenting cell -T cell ratios, did not aff ect CD62L expression. We argue that the mucosal microenvironmental factors RA and TGF-β , which can be secreted by mucosal DC ( 19, 32 ) , modulate the expression of CD62L upon intestinal T-cell activation. In particular, Seibold et al. ( 26 ) refl ects TGF-β and RA-dependent imprinting by mucosal antigen presenting cell rather than a regulatory T-cell function. As Foxp3 was normally induced on polyclonally stimulated CD4 + T cells from CD38 − / − mice by TGF-β and RA (not shown), it seems unlikely that CD38 is essential for the generation of Foxp3 + Tregs in vitro . Although an association between RA and CD38 was reported for human leukemia cell lines and in B cells ( 35 -39 ) , we are the fi rst to report that RA induces CD38 expression in primary T cells. Th e role of CD38 in T-cell diff erentiation is unclear. While there are no published reports demonstrating a functional role for CD38 on T cells, unpublished fi ndings show that T cells from CD38 − / − mice do exhibit intrinsic functional defects (Frances Lund). Nevertheless, there is no evidence that these mice develop an intestinal pathology. It has been demonstrated that CD38 has an important role in B-cell responses ( 40 ) . Furthermore, CD38 has a crucial role in the migration of DC ( 41 ) and therefore one could question a role for CD38 in the migration of RA and TGF-β -imprinted CD62L neg CD38 + T cells to the small-intestinal mucosa. Moreover, the strength of the antigen presenting cell -T cell interaction may be infl uenced by the expression levels of CD38 on T cells, as human CD38 associates with the TCR ( 42 ) and CD38 can be recruited to the immunologic synapse upon antigen-mediated T-cell activation ( 43 ) .
COLON/SMALL BOWEL
Possibly, CD62L 
CD38
neg CD4 + T cells also contained IFN-γ aft er restimulation. We propose that future analysis of the anti-infl ammatory and proinfl ammatory cytokine profi le of this cellular subtype in diff erent patient cohorts should ameliorate disease profi ling in chronic intestinal disease. Currently, most of these studies are performed with total PBMC. By preselecting for gut-imprinted cells instead of restimulating total PBMC the threshold of detection of T-cell responses to luminal antigens is lowered and the specifi city of the readout is enhanced.
Overall better functional analysis of mucosally imprinted T cells in the periphery may have important consequences for subtyping IBD and celiac disease patients and help in evaluating therapy responsiveness.
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+ CD62L neg CD38 + Identifies Mucosal T Cells
